Su, Q.; Yao, J.; Farooq, M.A.; Ajmal, I.; Duan, Y.; He, C.; Hu, X.; Jiang, W.
Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation. Cells 2024, 13, 555.
https://doi.org/10.3390/cells13060555
AMA Style
Su Q, Yao J, Farooq MA, Ajmal I, Duan Y, He C, Hu X, Jiang W.
Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation. Cells. 2024; 13(6):555.
https://doi.org/10.3390/cells13060555
Chicago/Turabian Style
Su, Qiong, Jie Yao, Muhammad Asad Farooq, Iqra Ajmal, Yixin Duan, Cong He, Xuefei Hu, and Wenzheng Jiang.
2024. "Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation" Cells 13, no. 6: 555.
https://doi.org/10.3390/cells13060555
APA Style
Su, Q., Yao, J., Farooq, M. A., Ajmal, I., Duan, Y., He, C., Hu, X., & Jiang, W.
(2024). Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation. Cells, 13(6), 555.
https://doi.org/10.3390/cells13060555
